Literature DB >> 18774122

Diabetic macular edema: what is focal and what is diffuse?

David J Browning1, Michael M Altaweel, Neil M Bressler, Susan B Bressler, Ingrid U Scott.   

Abstract

PURPOSE: To review the available information on classification of diabetic macular edema (DME) as focal or diffuse.
DESIGN: Interpretive essay.
METHODS: Literature review and interpretation.
RESULTS: The terms focal diabetic macular edema and diffuse diabetic macular edema frequently are used without clear definitions. Published definitions often use different examination methods and often are inconsistent. Evaluating published information on the prevalence of focal and diffuse DME, the responses of focal and diffuse DME to treatments, and the importance of focal and diffuse DME in assessing prognosis is hindered because the terms are used inconsistently. A newer vocabulary may be more constructive, one that describes discrete components of the concepts such as extent and location of macular thickening, involvement of the center of the macula, quantity and pattern of lipid exudates, source of fluorescein leakage, and regional variation in macular thickening and that distinguishes these terms from the use of the term focal when describing one type of photocoagulation technique. Developing methods for assessing component variables that can be used in clinical practice and establishing reproducibility of the methods are important tasks.
CONCLUSIONS: Little evidence exists that characteristics of DME described by the terms focal and diffuse help to explain variation in visual acuity or response to treatment. It is unresolved whether a concept of focal and diffuse DME will prove clinically useful despite frequent use of the terms when describing management of DME. Further studies to address the issues are needed.

Entities:  

Mesh:

Year:  2008        PMID: 18774122      PMCID: PMC2785449          DOI: 10.1016/j.ajo.2008.07.013

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  85 in total

1.  OCT vitreoretinal interface patterns.

Authors:  D Thomas; D A H Laidlaw
Journal:  Eye (Lond)       Date:  2003-05       Impact factor: 3.775

2.  Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.

Authors:  A P Ciardella; J Klancnik; W Schiff; G Barile; K Langton; S Chang
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

3.  The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema.

Authors:  Se Woong Kang; Choul Yong Park; Don-Il Ham
Journal:  Am J Ophthalmol       Date:  2004-02       Impact factor: 5.258

4.  Cystoid maculopathy in diabetics.

Authors:  A Patz
Journal:  Arch Ophthalmol       Date:  1976-05

Review 5.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Authors:  C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

6.  Subthreshold micropulse diode laser treatment in diabetic macular oedema.

Authors:  M L Laursen; F Moeller; B Sander; A K Sjoelie
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

7.  Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema.

Authors:  François Audren; Michel Tod; Pascale Massin; Rym Benosman; Belkacem Haouchine; Ali Erginay; Charles Caulin; Alain Gaudric; Jean-François Bergmann
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-10       Impact factor: 4.799

8.  Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography.

Authors:  David J Browning; Michael D McOwen; Robert M Bowen; Tisha L O'Marah
Journal:  Ophthalmology       Date:  2004-04       Impact factor: 12.079

9.  Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.

Authors:  Pascale Massin; François Audren; Belkacem Haouchine; Ali Erginay; Jean-François Bergmann; Rym Benosman; Charles Caulin; Alain Gaudric
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

10.  Effective treatment of diffuse diabetic macular edema by temporal grid pattern photocoagulation.

Authors:  Masahiko Shimura; Kanako Yasuda; Toru Nakazawa; Satsuki Ota; Makoto Tamai
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2004 Jul-Aug
View more
  42 in total

1.  In vivo adaptive optics microvascular imaging in diabetic patients without clinically severe diabetic retinopathy.

Authors:  Stephen A Burns; Ann E Elsner; Toco Y Chui; Dean A Vannasdale; Christopher A Clark; Thomas J Gast; Victor E Malinovsky; Anh-Danh T Phan
Journal:  Biomed Opt Express       Date:  2014-02-27       Impact factor: 3.732

2.  Qualitative and quantitative OCT response of diffuse diabetic macular oedema to macular laser photocoagulation.

Authors:  R Vemala; S Koshy; S Sivaprasad
Journal:  Eye (Lond)       Date:  2011-04-15       Impact factor: 3.775

3.  Current status in diabetic macular edema treatments.

Authors:  Pedro Romero-Aroca
Journal:  World J Diabetes       Date:  2013-10-15

4.  Kernel regression based segmentation of optical coherence tomography images with diabetic macular edema.

Authors:  Stephanie J Chiu; Michael J Allingham; Priyatham S Mettu; Scott W Cousins; Joseph A Izatt; Sina Farsiu
Journal:  Biomed Opt Express       Date:  2015-03-09       Impact factor: 3.732

5.  Is intravitreal bevacizumab treatment effective in diffuse diabetic macular edema?

Authors:  Sabine Biester; Focke Ziemssen; Karl Ulrich Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-07       Impact factor: 3.117

6.  Association between cystoid spaces on indocyanine green hyperfluorescence and optical coherence tomography after vitrectomy for diabetic macular oedema.

Authors:  S Yoshitake; T Murakami; A Uji; K Ogino; T Horii; M Hata; S Arichika; K Nishijima; N Yoshimura
Journal:  Eye (Lond)       Date:  2014-01-24       Impact factor: 3.775

7.  Real-world outcomes of two-year Conbercept therapy for diabetic macular edema.

Authors:  Yong Cheng; Li Yuan; Ming-Wei Zhao; Tong Qian
Journal:  Int J Ophthalmol       Date:  2021-03-18       Impact factor: 1.779

Review 8.  Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.

Authors:  Gianni Virgili; Francesca Menchini; Giovanni Casazza; Ruth Hogg; Radha R Das; Xue Wang; Manuele Michelessi
Journal:  Cochrane Database Syst Rev       Date:  2015-01-07

9.  Association of the extent of diabetic macular edema as assessed by optical coherence tomography with visual acuity and retinal outcome variables.

Authors:  David J Browning; Rajendra S Apte; Susan B Bressler; Kakarla V Chalam; Ronald P Danis; Matthew D Davis; Craig Kollman; Haijing Qin; Srinivas Sadda; Ingrid U Scott
Journal:  Retina       Date:  2009-03       Impact factor: 4.256

10.  Comparison of serum glycosylated hemoglobin levels in patients with diabetic cystoid macular edema with and without serous macular detachment.

Authors:  Burak Turgut; Fatih Cem Gul; Nevin Ilhan; Tamer Demir; Ulku Celiker
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.